![1]()
News
MAT access helps address opioid use disorder
April 18, 2019
PHILADELPHIA – Incarceration is an accelerant in the crisis of opioid use disorder.
![1]()
News
Ibrexafungerp effective against C. auris in two early case reports
April 18, 2019
Early findings from the CARES study show clinical improvement and eradication of candidemia.
![1]()
News
Candida auris: Dangerous and here to stay
April 18, 2019
Mortality rates topped 50% during a protracted outbreak at a Spanish hospital.
![1]()
News
Epinephrine linked with more refractory cardiogenic shock after acute MI
April 18, 2019
Is there a difference in safety and efficacy when using epinephrine versus norepinephrine for cardiogenic shock after successful reperfusion in acute myocardial infarction (AMI)?
![1]()
News
Poor response to statins hikes risk of cardiovascular events
April 17, 2019
Patients with better outcomes were more likely to have initiated therapy with a more potent drug.
![1]()
News
Prevalence and outcomes of incidental imaging findings
April 17, 2019
How frequently are incidental findings on imaging identified and how often do these findings represent true pathology?
![1]()
News
More Medicare beneficiaries receiving hospice care services than in previous years
April 16, 2019
For patients with Medicare Fee-for-Service and Medicare Advantage, what are the trends regarding where they die and the type of health care received around the time of death?
![1]()
News
Statin exposure associated with idiopathic inflammatory myositis
April 15, 2019
What is the association between exposure to statin medications and histologically confirmed idiopathic inflammatory myositis?
![1]()
News
PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan
April 14, 2019
NEW ORLEANS – “The early improvement in postdischarge outcomes supports the in-hospital initiation of sacubitril/valsartan.” – Dr. Adam D. DeVore
![1]()
News
Cost gap widens between brand-name, generic drugs
April 12, 2019
Generics represent almost 90% of prescriptions filled in the United States but less than 25% of spending.








